94 related articles for article (PubMed ID: 12966667)
1. [Hypertrophy and ventricular remodeling in systemic arterial hypertension: role of AT1 receptors].
Troyo Barriga P
Arch Cardiol Mex; 2003; 73 Suppl 1():S146-9. PubMed ID: 12966667
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
[TBL] [Abstract][Full Text] [Related]
3. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
5. [Hypertension and the progression of organ damage].
Morganti A
Ital Heart J; 2000 Jun; 1 Suppl 2():100-3. PubMed ID: 10905136
[TBL] [Abstract][Full Text] [Related]
6. [Cardioprotective and cardio-reparative drugs].
Bolaños F
Rev Esp Cardiol; 1997; 50 Suppl 4():53-6. PubMed ID: 9411588
[TBL] [Abstract][Full Text] [Related]
7. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
8. [Paradigms and paradoxes of left ventricular hypertrophy: from the research laboratory to the clinical consultation].
Escudero EM; Pinilla OA
Arch Cardiol Mex; 2007; 77(3):237-48. PubMed ID: 18050937
[TBL] [Abstract][Full Text] [Related]
9. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
10. Respective impacts of aortic stenosis and systemic hypertension on left ventricular hypertrophy.
Garcia D; Pibarot P; Kadem L; Durand LG
J Biomech; 2007; 40(5):972-80. PubMed ID: 16750211
[TBL] [Abstract][Full Text] [Related]
11. Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction.
Waller C; Hiller KH; Pfaff D; Gattenlöhner S; Ertl G; Bauer WR
Microvasc Res; 2008 Jan; 75(1):104-11. PubMed ID: 17540413
[TBL] [Abstract][Full Text] [Related]
12. [Obesity and cardiac failure].
Galinier M; Pathak A; Roncalli J; Massabuau P
Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease.
Díez J; González A; López B; Querejeta R
Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):209-16. PubMed ID: 16265485
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.
Kawano S; Kubota T; Monden Y; Kawamura N; Tsutsui H; Takeshita A; Sunagawa K
Cardiovasc Res; 2005 Sep; 67(4):689-98. PubMed ID: 15921667
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy and hypertension.
Katibi IA
Niger J Med; 2004; 13(1):8-17. PubMed ID: 15296101
[TBL] [Abstract][Full Text] [Related]
16. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
[TBL] [Abstract][Full Text] [Related]
18. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
20. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
